分次伽玛刀放射外科的新兴适应证
该研究报告了使用可复位、无创固定系统进行分次伽玛刀放射外科(GKRS)治疗34例患者(37个肿瘤)的经验,适应证包括体积>10 cc或毗邻视路的良性肿瘤、旨在保留听力的前庭神经鞘瘤以及既往接受过单次GKRS的肿瘤。末次随访时,21例毗邻视路肿瘤患者视力稳定或改善,4例前庭神经鞘瘤患者维持可用听力,未报告严重不良事件。作者认为分次GKRS在大脑膜瘤、毗邻视路肿瘤、旨在保留听力的前庭神经鞘瘤及既往治疗肿瘤再照射中耐受良好。
要点
- 分次GKRS适应证包括>10 cc或毗邻视路的良性肿瘤、旨在保留听力的前庭神经鞘瘤、既往单次GKRS照射的肿瘤。
- 34例患者共37个肿瘤接受分次GKRS,包括15例脑膜瘤、11例垂体腺瘤、6例脑转移瘤、4例前庭神经鞘瘤、1例血管瘤。
- 21例毗邻视路肿瘤患者视力稳定或改善,4例前庭神经鞘瘤患者维持可用听力,未报告严重不良事件。
核心结论
- 分次GKRS在大脑膜瘤、毗邻视路肿瘤、旨在保留听力的前庭神经鞘瘤及既往治疗肿瘤再照射中耐受良好。
研究设计与样本
- 单中心经验报告,2013年8月至2015年2月共34例患者接受分次GKRS,使用Extend系统(Leksell Gamma Knife Perfexion,Elekta)无创固定。
主要发现
- 共治疗37个肿瘤:15个脑膜瘤、11个垂体腺瘤、6个脑转移瘤、4个前庭神经鞘瘤、1个血管瘤。
- 末次随访时,21例毗邻视路肿瘤患者视力稳定或改善,4例前庭神经鞘瘤患者维持可用听力。
- 未报告严重不良事件。
关键数值与推荐
- 分次GKRS候选适应证:体积>10 cc或毗邻视路的良性肿瘤、旨在保留听力的前庭神经鞘瘤、既往接受单次GKRS照射的肿瘤。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Gamma Knife radiosurgery (GKRS) allows for the treatment of intracranial tumors with a high degree of dose conformality and precision. There are, however, certain situations wherein the dose conformality of GKRS is desired, but single session treatment is contraindicated. In these situations, a traditional pin-based GKRS head frame cannot be used, as it precludes fractionated treatment. OBJECTIVE: To report our experience in treating patients with fractionated GKRS using a relocatable, noninvasive immobilization system. METHODS: Patients were considered candidates for fractionated GKRS if they had one or more of the following indications: a benign tumor >10 cc in volume or abutting the optic pathway, a vestibular schwannoma with the intent of hearing preservation, or a tumor previously irradiated with single fraction GKRS. The immobilization device used for all patients was the Extend system (Leksell Gamma Knife Perfexion, Elekta, Kungstensgatan, Stockholm). RESULTS: We identified 34 patients treated with fractionated GKRS between August 2013 and February 2015. There were a total of 37 tumors treated including 15 meningiomas, 11 pituitary adenomas, 6 brain metastases, 4 vestibular schwannomas, and 1 hemangioma. At last follow-up, all 21 patients treated for perioptic tumors had stable or improved vision and all 4 patients treated for vestibular schwannoma maintained serviceable hearing. No severe adverse events were reported. CONCLUSION: Fractionated GKRS was well-tolerated in the treatment of large meningiomas, perioptic tumors, vestibular schwannomas with intent of hearing preservation, and in reirradiation of previously treated tumors.
引用
- McTyre E, Helis CA, Farris M, et al. Emerging Indications for Fractionated Gamma Knife Radiosurgery. Neurosurgery. 2017. PMID: 28536486. doi:10.1227/NEU.0000000000001227
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。